Literature DB >> 28941090

Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys.

Louisa Degenhardt1, Meyer Glantz2, Sara Evans-Lacko3, Ekaterina Sadikova4, Nancy Sampson4, Graham Thornicroft3, Sergio Aguilar-Gaxiola5, Ali Al-Hamzawi6, Jordi Alonso7, Laura Helena Andrade8, Ronny Bruffaerts9, Brendan Bunting10, Evelyn J Bromet11, José Miguel Caldas de Almeida12, Giovanni de Girolamo13, Silvia Florescu14, Oye Gureje15, Josep Maria Haro16, Yueqin Huang17, Aimee Karam18, Elie G Karam18,19, Andrzej Kiejna20, Sing Lee21, Jean-Pierre Lepine22, Daphna Levinson23, Maria Elena Medina-Mora24, Yosikazu Nakamura25, Fernando Navarro-Mateu26, Beth-Ellen Pennell27, José Posada-Villa28, Kate Scott29, Dan J Stein30, Margreet Ten Have31, Yolanda Torres32, Zahari Zarkov33, Somnath Chatterji34, Ronald C Kessler4.   

Abstract

Substance use is a major cause of disability globally. This has been recognized in the recent United Nations Sustainable Development Goals (SDGs), in which treatment coverage for substance use disorders is identified as one of the indicators. There have been no estimates of this treatment coverage cross-nationally, making it difficult to know what is the baseline for that SDG target. Here we report data from the World Health Organization (WHO)'s World Mental Health Surveys (WMHS), based on representative community household surveys in 26 countries. We assessed the 12-month prevalence of substance use disorders (alcohol or drug abuse/dependence); the proportion of people with these disorders who were aware that they needed treatment and who wished to receive care; the proportion of those seeking care who received it; and the proportion of such treatment that met minimal standards for treatment quality ("minimally adequate treatment"). Among the 70,880 participants, 2.6% met 12-month criteria for substance use disorders; the prevalence was higher in upper-middle income (3.3%) than in high-income (2.6%) and low/lower-middle income (2.0%) countries. Overall, 39.1% of those with 12-month substance use disorders recognized a treatment need; this recognition was more common in high-income (43.1%) than in upper-middle (35.6%) and low/lower-middle income (31.5%) countries. Among those who recognized treatment need, 61.3% made at least one visit to a service provider, and 29.5% of the latter received minimally adequate treatment exposure (35.3% in high, 20.3% in upper-middle, and 8.6% in low/lower-middle income countries). Overall, only 7.1% of those with past-year substance use disorders received minimally adequate treatment: 10.3% in high income, 4.3% in upper-middle income and 1.0% in low/lower-middle income countries. These data suggest that only a small minority of people with substance use disorders receive even minimally adequate treatment. At least three barriers are involved: awareness/perceived treatment need, accessing treatment once a need is recognized, and compliance (on the part of both provider and client) to obtain adequate treatment. Various factors are likely to be involved in each of these three barriers, all of which need to be addressed to improve treatment coverage of substance use disorders. These data provide a baseline for the global monitoring of progress of treatment coverage for these disorders as an indicator within the SDGs.
© 2017 World Psychiatric Association.

Entities:  

Keywords:  Substance use disorders; United Nations Sustainable Development Goals; World Health Organization; alcohol; drugs; treatment coverage

Year:  2017        PMID: 28941090      PMCID: PMC5608813          DOI: 10.1002/wps.20457

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  31 in total

1.  National trends in alcohol pharmacotherapy: Findings from an Australian claims database.

Authors:  Kirsten C Morley; Warren Logge; Sallie-Anne Pearson; Andrew Baillie; Paul S Haber
Journal:  Drug Alcohol Depend       Date:  2016-06-29       Impact factor: 4.492

2.  Reducing the treatment gap for mental disorders: a WPA survey.

Authors:  Vikram Patel; Mario Maj; Alan J Flisher; Mary J De Silva; Mirja Koschorke; Martin Prince
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

Review 3.  Psychosocial approaches to alcohol use disorders since 1940: a review.

Authors:  Barbara S McCrady; Mandy D Owens; Adrienne Z Borders; Julie M Brovko
Journal:  J Stud Alcohol Drugs Suppl       Date:  2014

4.  Substance dependence among those without symptoms of substance abuse in the World Mental Health Survey.

Authors:  Luise Lago; Meyer D Glantz; Ronald C Kessler; Nancy A Sampson; Ali Al-Hamzawi; Silvia Florescu; Jacek Moskalewicz; Sam Murphy; Fernando Navarro-Mateu; Yolanda Torres de Galvis; Maria Carmen Viana; Miguel Xavier; Louisa Degenhardt
Journal:  Int J Methods Psychiatr Res       Date:  2017-02-17       Impact factor: 4.035

5.  HIV and risk environment for injecting drug users: the past, present, and future.

Authors:  Steffanie A Strathdee; Timothy B Hallett; Natalia Bobrova; Tim Rhodes; Robert Booth; Reychad Abdool; Catherine A Hankins
Journal:  Lancet       Date:  2010-07-24       Impact factor: 79.321

6.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

Authors:  Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

Review 7.  Pharmacotherapies for cannabis dependence.

Authors:  Kushani Marshall; Linda Gowing; Robert Ali; Bernard Le Foll
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

Review 8.  Disulfiram for the treatment of cocaine dependence.

Authors:  Pier Paolo Pani; Emanuela Trogu; Rosangela Vacca; Laura Amato; Simona Vecchi; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 9.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations.

Authors:  Tarun Dua; Corrado Barbui; Nicolas Clark; Alexandra Fleischmann; Vladimir Poznyak; Mark van Ommeren; M Taghi Yasamy; Jose Luis Ayuso-Mateos; Gretchen L Birbeck; Colin Drummond; Melvyn Freeman; Panteleimon Giannakopoulos; Itzhak Levav; Isidore S Obot; Olayinka Omigbodun; Vikram Patel; Michael Phillips; Martin Prince; Afarin Rahimi-Movaghar; Atif Rahman; Josemir W Sander; John B Saunders; Chiara Servili; Thara Rangaswamy; Jürgen Unützer; Peter Ventevogel; Lakshmi Vijayakumar; Graham Thornicroft; Shekhar Saxena
Journal:  PLoS Med       Date:  2011-11-15       Impact factor: 11.069

View more
  59 in total

1.  Optimization of a multivalent peptide vaccine for nicotine addiction.

Authors:  David F Zeigler; Richard Roque; Christopher H Clegg
Journal:  Vaccine       Date:  2019-02-13       Impact factor: 3.641

2.  Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.

Authors:  Meredith G Harris; Chrianna Bharat; Meyer D Glantz; Nancy A Sampson; Ali Al-Hamzawi; Jordi Alonso; Ronny Bruffaerts; José Miguel Caldas de Almeida; Alfredo H Cia; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Hristo Hinkov; Elie G Karam; Georges Karam; Sing Lee; Jean-Pierre Lépine; Daphna Levinson; Victor Makanjuola; John McGrath; Zeina Mneimneh; Fernando Navarro-Mateu; Marina Piazza; José Posada-Villa; Charlene Rapsey; Hisateru Tachimori; Margreet Ten Have; Yolanda Torres; Maria Carmen Viana; Somnath Chatterji; Alan M Zaslavsky; Ronald C Kessler; Louisa Degenhardt
Journal:  Addiction       Date:  2019-06-02       Impact factor: 6.526

3.  Patterns of care and dropout rates from outpatient mental healthcare in low-, middle- and high-income countries from the World Health Organization's World Mental Health Survey Initiative.

Authors:  Daniel Fernández; Daniel Vigo; Nancy A Sampson; Irving Hwang; Sergio Aguilar-Gaxiola; Ali O Al-Hamzawi; Jordi Alonso; Laura Helena Andrade; Evelyn J Bromet; Giovanni de Girolamo; Peter de Jonge; Silvia Florescu; Oye Gureje; Hristo Hinkov; Chiyi Hu; Elie G Karam; Georges Karam; Norito Kawakami; Andrzej Kiejna; Viviane Kovess-Masfety; Maria E Medina-Mora; Fernando Navarro-Mateu; Akin Ojagbemi; Siobhan O'Neill; Marina Piazza; Jose Posada-Villa; Charlene Rapsey; David R Williams; Miguel Xavier; Yuval Ziv; Ronald C Kessler; Josep M Haro
Journal:  Psychol Med       Date:  2020-04-28       Impact factor: 7.723

4.  A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability.

Authors:  Neomi van Duijvenbode; Joanne E L VanDerNagel
Journal:  Eur Addict Res       Date:  2019-07-22       Impact factor: 3.015

5.  The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys.

Authors:  Louisa Degenhardt; Chrianna Bharat; Meyer D Glantz; Nancy A Sampson; Kate Scott; Carmen C W Lim; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Laura H Andrade; Evelyn J Bromet; Ronny Bruffaerts; Brendan Bunting; Giovanni de Girolamo; Oye Gureje; Josep Maria Haro; Meredith G Harris; Yanling He; Peter de Jonge; Elie G Karam; Georges E Karam; Andrzej Kiejna; Sing Lee; Jean-Pierre Lepine; Daphna Levinson; Victor Makanjuola; Maria Elena Medina-Mora; Zeina Mneimneh; Fernando Navarro-Mateu; José Posada-Villa; Dan J Stein; Hisateru Tachimori; Yolanda Torres; Zahari Zarkov; Somnath Chatterji; Ronald C Kessler
Journal:  Int J Drug Policy       Date:  2019-06-28

6.  Burden of Mental, Neurological, Substance Use Disorders and Self-Harm in North America: A Comparative Epidemiology of Canada, Mexico, and the United States.

Authors:  Daniel Vigo; Laura Jones; Graham Thornicroft; Rifat Atun
Journal:  Can J Psychiatry       Date:  2019-11-20       Impact factor: 4.356

7.  Drug Use Disorders and Violence: Associations With Individual Drug Categories.

Authors:  Shaoling Zhong; Rongqin Yu; Seena Fazel
Journal:  Epidemiol Rev       Date:  2020-01-31       Impact factor: 6.222

8.  The Implementation of the WHO Mental Health Gap Intervention Guide (mhGAP-IG) in Ukraine, Armenia, Georgia and Kyrgyz Republic.

Authors:  Irina Pinchuk; Yulia Yachnik; Oksana Kopchak; Kristine Avetisyan; Khachatur Gasparyan; Gayane Ghazaryan; Eka Chkonia; Lilya Panteleeva; Anthony Guerrero; Norbert Skokauskas
Journal:  Int J Environ Res Public Health       Date:  2021-04-21       Impact factor: 3.390

9.  Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

10.  Evaluation of a Web-based Psychosocial Education and Peer Support Program for Alcohol Use Concerns.

Authors:  Dezarie Moskal; Holly Whitaker; Julia Bernstein; Stephen A Maisto; Gerard J Connors
Journal:  Alcohol Treat Q       Date:  2021-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.